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Objective: To study prevalence of diabetes type-2 and pulmonary tuberculosis among Fili-
pino patients and treatment out comes. Tuberculosis centre of Dammam medical complex
(MOH) is a referral centre for the Eastern Saudi Arabia where patients from all government
and private hospitals having open pulmonary tuberculosis are admitted for isolation till
they are rendered noninfectious. All patients are treated for 6 months under DOTS strategy
with 4 drugs (2HRZE) for 2 months as initial intensive phase and 2 drugs (HR) for 4 months
as continuation phase.
Methods and materials: We retrospectively reviewed clinical records of 1388 patients admit-
ted with open pulmonary tuberculosis between Jan- 2003 and June-2010.
Results: Among 1388 patients, 39% (n = 542) were Saudis and 61% (n = 846) were non-Saudis.
Among these 12.39% (n = 172) were Filipinos,153 males and 19 females respectively. Out of
1388 patients, 114 (7.17%) were found to have diabetes type-2. Among these diabetics,
majority n = 91 (79.82%) were Filipinos. Sputum conversion was late in diabetic patients
resulting in relatively longer hospital stay compared to fellow patients having only tuber-
culosis.
Conclusion: Our study has shown that one possible risk factor for tuberculosis is diabetes.
Majority of TB patients having diabetes type-2, n = 91 (79.82%) were Filipinos. Their sputum
conversion was relatively late and their hospital stay was longer than their fellow patients
having only tuberculosis. Our findings are in agreement with the current literature on the
correlation of diabetes and tuberculosis.
 2012 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
In view of accumulating evidence, it is a very well-established
fact that there is a correlation between diabetes mellitus
type-2 and tuberculosis (TB). Patients with diabetes melli--African Society for Myco
SBAH-city Rehabilitation
(L.A. Chaudhry).tus type-2 are in particular more prone to getting infec-
tions, including TB, which are more difficult to treat because
of their inherent weak immune system; the high prevalence
of diabetes could adversely affect global TB control efforts
[1,2].bacteriology. All rights reserved.
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180 million people are suffering from diabetes worldwide,
and it is likely to double in the next 19–20 years, i.e., by
2030. Being that TB is an air-born infectious disease that
transmits from person to person, each index case of TB can
infect on average 10 persons in a year. That is why it is said
‘cure of one is safety of ten’. It is predicted that millions of
the world population will develop diabetes by 2030, especially
in countries that are endemic for TB [3,4]. The countries like
China and India with large populations and low to middle in-
comes have the highest number of TB patients and are facing
a rapid increase in the number of diabetic patients as well.
Since the risk of developing TB is more likely in diabetic
patients, this correlation between diabetes and TB could have
a negative impact on TB control programs [5–7].
In this study, the prevalence of diabetes and its correlation
with TB among Filipino patients admitted at the TB center be-
tween January 2003 and June 2010 and their treatment out-
come in terms of sputum conversion and their hospital stay
were evaluated retrospectively. All patients were started with
initial intensive phase therapy with the standard first-line
four-drug combination based on their body weight (Isoniazid
[INH] 5 mg /kg, Rifampicin [Rifadin] 10 mg /kg, Ethambutol
15 mg /kg, Pyrazinamide 25 mg /kg). This is a referral center
for the Eastern region of Saudi Arabia where patients present-
ing with open pulmonary tuberculosis are admitted from all
government and private hospitals until they are rendered
non-infectious by DOTS (directly observed therapy) strategy.
Materials and methods
Clinical records of all 1388 patients admitted during the peri-
od between January 2003 and June 2010 were retrieved to de-
tect the number of patients with diabetes and TB. Since the
majority (79.82%) of diabetics was Filipinos, their responseTable 1 – Admissions at Tuberculosis Centre of Dammam
Medical Complex (MOH) between January 2003 and June
2010.
Patient’s Origin Number of
TB patients
Percentage TB +
diabetics
Saudi 542 39 15
Other non-Saudi 674 48.61 8
Number of Filipinos 172 12.39 91 (79.82%)
Total 1388 114 (7.17%)
Table 2 – Findings in 172 TB patients of Filipino origi
Without t
Number of patients
Percentage
81 {62 ma
47
Age (years) 26–57 yrs
Fasting blood glucose (mg/dL) Normal
HbA1c (%)
Duration of hospital stay (days) 55–90to anti-TB treatment and their hospital stay was studied
when compared with those with only pulmonary TB.Results
Among the total of 1388 patients, 39% (n = 542) were Saudis
and 61% (n = 846) were non-Saudis. Filipinos alone consti-
tuted 12.39% of total admissions and 20.3% of non-Saudis.
The total number of TB patients also diagnosed with diabetes
was 114 (7.17%). Among these diabetics, 79.82% (n = 91) were
Filipinos. Among the total of 172 Filipinos, 153 were males
and 19 were females. Among the 172 Filipinos, the majority
(53%, n = 91) also had type-2 diabetes, and their age ranged
between 32 and 57 years old. All of those Filipinos with diabe-
tes were males; none of the 19 females had diabetes (see
Table 1).
Diabetic control was poor at the time of admission; their
fasting blood sugar (FBS) ranged between 154 and 230mg/dL.
Glycated hemoglobin (HbA1c) was performed on only 11
patients and ranged between 7.8% and 9.3%, which again
indicates chronic hyperglycemia. Those with both TB and
diabetes stayed longer in the hospital 70–110 days owing to
their late sputum conversion on direct smear when compared
with their fellow non-diabetic TB patients 55–90 days (see
Table 2).
Discussion
There is a correlation between diabetes mellitus type-2 and
TB, mainly because patients with diabetes type-2 have a weak
immune system and are therefore more prone to getting
infections, including TB. Global TB control efforts could be ad-
versely affected by a high prevalence of diabetes [8–12].
Each year, about 8.8 million people develop active tubercu-
losis, which commonly affects lungs, and millions of people
die because of this highly contagious infection. It is said that
one third of the world population is infected with Mycobacte-
rium tuberculosis, but all of those infected do not develop ac-
tive TB because normally the immune system contains the
infection. However, in some people the bacteria remain dor-
mant and could become active causing disease at a later
stage, especially in those with risk factors such as old age,
diabetes, those on immunosuppressive treatments, and HIV
patients [13–16].
According to some surveys taken in the Philippines, a high
prevalence of diabetes among Filipinos, especially those livingn.
ype-2 diabetes With type-2 diabetes
les & 19 females} 91 males
53
32–57 yrs
154–230
7.8–9.3
11 patients
70–110
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patients were newly diagnosed [17].
A few other studies have also suggested that the incidence
and prevalence of diabetes—especially type-2 diabetes—is
higher in Filipinos [18–20]. Various population groups in the
United States of America have different prevalence rates
depending on ethnicity, migrants or non-migrants, and those
living in rural and urban areas. Filipinos are the highest immi-
grant group in the USA, and Filipino-American men, espe-
cially those who are obese, have the highest prevalence of
diabetes type-2 [21–27].
A systemic review and meta-analysis in the USA of 13
observational studies by Christie Y. Jeon and Megan B. Murray
(including more than 17,000 TB patients) showed that those
with diabetes had a threefold increased risk of developing
active TB when compared with non-diabetics.
The majority 53% (n = 91) of Filipino male patients admit-
ted with open pulmonary TB also had uncontrolled diabetes
type-2. Their fasting blood sugar levels ranged from 154 to
230. Glycated hemoglobin (Hb-A1c) was performed on only
11 patients, and the results ranged from 7.8% to 9.3%. This
indicates that chronic high blood sugar increases the chances
of developing active TB.
Diabetics are not only more prone to contracting TB, but
their response to initial intensive phase 4-drug anti-TB treat-
ment is slow as well. This was clearly observed in this cohort
of Filipino patients in our study who stayed longer in the
hospital 70–110 days owing to their late sputum conversion
when compared with their fellow non-diabetic patients
55–90 days. It is likely owing to altered or impaired immune
system response in diabetic patients. None of the diabetic
Filipino patients had multi-drug resistant TB, except one
diabetic male patient who was reported resistant only to
INH at 69 days of treatment. All Filipino diabetic patients in
this study were males; none of the Filipino females had
diabetes.
Conclusion
Filipino patients in this study showed that there was a high
prevalence of diabetes among Filipino male patients, and
there is a correlation between diabetes and TB. This combina-
tion affects the response and outcome of anti-TB treatment.
These findings are in agreement with the current literature
on the correlation of diabetes and TB. Clinicians treating pa-
tients with diabetes and presenting with respiratory symp-
toms should have a high index of suspicion for TB.
In Saudi Arabia the prevalence of diabetes is 23.7%, which
is quite high, along with a very high incidence of childhood
obesity. Preventing obesity, which is a risk factor for develop-
ing diabetes, will help to reduce the future burden of TB.Acknowledgement
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